Bioxytran, Inc. (OTCMKTS:BIXT) Short Interest Update

Bioxytran, Inc. (OTCMKTS:BIXT) was the target of a significant increase in short interest during the month of July. As of July 31st, there was short interest totalling 38,600 shares, an increase of 235.7% from the July 15th total of 11,500 shares. Based on an average trading volume of 153,200 shares, the days-to-cover ratio is presently 0.3 days.

Bioxytran Trading Down 3.6 %

BIXT stock opened at $0.11 on Tuesday. The firm has a 50 day simple moving average of $0.11 and a 200-day simple moving average of $0.11. The company has a market capitalization of $18.78 million, a P/E ratio of -3.67 and a beta of -0.85. Bioxytran has a twelve month low of $0.07 and a twelve month high of $0.35.

Bioxytran Company Profile

Bioxytran, Inc, a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company's lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing.